Acute Cutaneous Squamous-Cell Carcinoma

Acute Cutaneous Squamous-Cell Carcinoma

Integrative transcriptomic analysis for linking acute stress responses to squamous cell carcinoma development

This study tested whether more acute molecular responses to UV and wounding overlapped with molecular signatures of cuSCC.

Scientific Reports
Clinical value of high-resolution dynamic contrast-enhanced (DCE) MRI in diagnosis of cutaneous squamous cell carcinoma.

While uncomplicated cases of skin cSCC can be treated with surgery topical therapy alone, more objective and non‐invasive examination methods are needed to guide clinicians...

Skin Research and Technology
Inhibitory effect of glutathione S-transferase A3 in the progression of cutaneous squamous cell carcinoma.

The present study was designed to explore the effect of GSTA3 on cSCC.

Journal of Cosmetic Dermatology

The Synthetic Flavonoid Derivative GL-V9 Induces Apoptosis and Autophagy in Cutaneous Squamous Cell Carcinoma via Suppressing AKT-Regulated HK2 and mTOR Signals.

Cutaneous squamous-cell carcinoma (cSCC) is one of most common type non-black skin cancer. The malignancy degree and the death risk cSCC patients are significantly higher than basal cell patients.

Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.

Given the increase in incidence rates and the frequent occurrence of subsequent cSCCs per patient, population-based data on the incidence rates of both first and multiple cSCCs are needed.

JAMA Dermatology
The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis

The study's aim was to estimate the incidence of cSCC after voriconazole exposure in patients with chronic pulmonary aspergillosis on a background of chronic lung disease.

Number of nodal metastases and the American Joint Committee on cancer staging of head and neck cutaneous squamous cell carcinoma: A multicenter study.

This study aimed to determine if the number of nodal metastases is an independent predictor of survival in HNcSCC, whether it provides additional prognostic information to the...

Oral Oncology
British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020.

The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for management cutaneous squamous cell carcinoma.

British Journal of Dermatology
Study Finds Incidence Rates of cSCC Continue to Increase, Especially Among Females

Study investigators indicated that these results call for the need to revise skin cancer health policies to be able to handle the increasing burden of keratinocyte carcinoma management.

FDA Approves Pembrolizumab for Cutaneous Squamous Cell Carcinoma

The FDA approved pembrolizumab for patients with recurrent or metastatic cutaneous squamous cell carcinoma that is not curable by surgery or radiation.


source list reference